Analyst Ratings for C4 Therapeutics (CCCC)
CCCC Rating Summary
CCCC Price Target Summary
- Highest: $30.00 (Brookline Capital Markets)
- Lowest: $7.00 (Barclays)
- Average: $15.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$15.67 (+389.6%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 76%
Avg. $ Target:
$15.67 (+389.6%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 76%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/9/2026 | JPMorgan | Anupam Rama | New Coverage | Overweight (N/A) |
10.00 (N/A) |
2.82 (3.20) |
13.48% | Details |
| 12/2/2025 | TD Cowen » Updated 2/26/2026 |
Tyler Van Buren | New Coverage | Buy (N/A) |
N/A (N/A) |
2.54 (3.20) |
25.98% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
